The current trial was sponsored by Novo Nordisk, the maker of Wegovy and Ozempic, and tracked patients for two years at locations worldwide. Half of the participants received weekly injections of semaglutide...
The brain has a remarkable ability to adapt in response to injury. Healthy regions can take over functions that the damaged parts used to perform. “We’re trying to promote conditions in the...
